AUSTIN, TEXAS / ACCESS Newswire / November 20, 2025 / TSS, Inc. (NASDAQ:TSSI), a data center services company that provides AI and high-performance computing (HPC) infrastructure and software integration services, today announced the release of its latest leadership paper: 2026 Trends in High-Performance Computing and Data Center Technology: A Strategic Guide for Procurement and Integration Leaders and Partners. As artificial intelligence (AI) becomes ubiquitous, HPC and data center technology infrastructure decisions have never been more consequential.

image for news TSS, Inc. Unveils 2026 Trends in High Performance Computing and Data Center Technology

New York, New York--(Newsfile Corp. - November 20, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.

image for news ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Perrigo Company plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - PRGO

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of PROS Holdings, Inc. (NYSE: PRO) to Thoma Bravo. Under the terms of the proposed transaction, shareholders of PROS will receive $23.25 in cash for each share of PROS that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the.

image for news Pros Holdings Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PROS Holdings, Inc. - PRO

The Explosive Numbers That Make Palantir a Buy Right Now — Positive

PLTR   24/7 Wall Street — November 20, 2025

Palantir Technologies ( NYSE:PLTR ) sits at the center of the artificial intelligence (AI) revolution as the leading enterprise AI software platform.

image for news The Explosive Numbers That Make Palantir a Buy Right Now

TDOC vs. LFMD: Which Telehealth Stock Is Better for Your Portfolio? — Positive

LFMD  TDOC   Zacks Investment Research — November 20, 2025

TDOC and LFMD face contrasting paths as telehealth demand climbs, with fundamentals and growth plans shaping which stock stands out.

image for news TDOC vs. LFMD: Which Telehealth Stock Is Better for Your Portfolio?

Novartis AG (NYSE: NVS) projects a stronger growth trajectory through 2030, lifting expectations for several key medicines and outlining a pipeline strategy it believes will sustain momentum well into the next decade.

image for news Novartis Projects Faster Growth Through 2030 After Raising Drug Forecasts

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Air Lease Corporation (NYSE: AL) to Sumitomo Corporation, SMBC Aviation Capital, Apollo and Brookfield. Under the terms of the proposed transaction, shareholders of Air Lease will receive $65.00 in cash for each share of Air Lease that they own. KSF is seeking to determine whether this consider.

image for news Air Lease Corp Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Air Lease Corporation - AL

COGT Stock Skyrockets 120% in a Month: Here's What You Need to Know — Positive

COGT   Zacks Investment Research — November 20, 2025

Cogent Biosciences soars as its bezuclastinib combo delivers strong phase III GIST results, driving momentum toward key regulatory filings.

image for news COGT Stock Skyrockets 120% in a Month: Here's What You Need to Know

FLEX vs. ROK: Which Stock Should Value Investors Buy Now? — Positive

FLEX  ROK   Zacks Investment Research — November 20, 2025

Investors with an interest in Electronics - Miscellaneous Products stocks have likely encountered both Flex (FLEX) and Rockwell Automation (ROK). But which of these two stocks presents investors with the better value opportunity right now?

image for news FLEX vs. ROK: Which Stock Should Value Investors Buy Now?

CM or IBN: Which Is the Better Value Stock Right Now? — Positive

CM  IBN   Zacks Investment Research — November 20, 2025

Investors with an interest in Banks - Foreign stocks have likely encountered both Canadian Imperial Bank (CM) and ICICI Bank Limited (IBN). But which of these two stocks presents investors with the better value opportunity right now?

image for news CM or IBN: Which Is the Better Value Stock Right Now?

PAHC or BSX: Which Is the Better Value Stock Right Now? — Neutral

BSX  PAHC   Zacks Investment Research — November 20, 2025

Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?

image for news PAHC or BSX: Which Is the Better Value Stock Right Now?

KTB or CTAS: Which Is the Better Value Stock Right Now? — Positive

CTAS  KTB   Zacks Investment Research — November 20, 2025

Investors interested in Textile - Apparel stocks are likely familiar with Kontoor Brands (KTB) and Cintas (CTAS). But which of these two companies is the best option for those looking for undervalued stocks?

image for news KTB or CTAS: Which Is the Better Value Stock Right Now?

OMCL or HIMS: Which Is the Better Value Stock Right Now? — Positive

HIMS  OMCL   Zacks Investment Research — November 20, 2025

Investors looking for stocks in the Medical Info Systems sector might want to consider either Omnicell (OMCL) or Hims & Hers Health, Inc. (HIMS). But which of these two companies is the best option for those looking for undervalued stocks?

image for news OMCL or HIMS: Which Is the Better Value Stock Right Now?

ERIC or IDCC: Which Is the Better Value Stock Right Now? — Positive

ERIC  IDCC   Zacks Investment Research — November 20, 2025

Investors interested in Wireless Equipment stocks are likely familiar with Ericsson (ERIC) and InterDigital (IDCC). But which of these two stocks presents investors with the better value opportunity right now?

image for news ERIC or IDCC: Which Is the Better Value Stock Right Now?

PAX or APO: Which Is the Better Value Stock Right Now? — Positive

APO  PAX   Zacks Investment Research — November 20, 2025

Investors interested in Financial - Investment Management stocks are likely familiar with Patria Investments (PAX) and Apollo Global Management Inc. (APO). But which of these two stocks presents investors with the better value opportunity right now?

image for news PAX or APO: Which Is the Better Value Stock Right Now?

Biohaven Insiders Bet $33 Million on a Turnaround — Positive

BHVN   MarketBeat — November 20, 2025

When corporate executives make multi-million-dollar personal investments in the company they lead, it is one of the most potent signals an investor can receive. At Biohaven NYSE: BHVN, that signal has just been sent loud and clear.

image for news Biohaven Insiders Bet $33 Million on a Turnaround

Want more income with less effort and capital? You'll need to choose your investments carefully, but it's possible to achieve amazing results with just $2,500 invested in a few stocks and exchange traded funds (ETFs).

image for news Want $3,500 per Year in Passive Income? Invest Just $2,500 in These Supersized Dividend Stocks

Retail Royalty: Why Walmart Continues to Eclipse Competitors — Negative

WMT   Zacks Investment Research — November 20, 2025

All signs pointed to the weak retail sentiment spilling over into Walmart's results, but the king of retail had other plans.

image for news Retail Royalty: Why Walmart Continues to Eclipse Competitors

Jacobs Q4 Earnings & Revenues Beat Estimates, Margins Expand Sharply — Positive

J   Zacks Investment Research — November 20, 2025

J posts strong Q4 results with EPS up 27.7% and margins expanding sharply, driven by broad market strength and solid execution.

image for news Jacobs Q4 Earnings & Revenues Beat Estimates, Margins Expand Sharply

VKTX Completes Enrollment in First Late-Stage Study on Obesity Drug — Positive

VKTX   Zacks Investment Research — November 20, 2025

Viking Therapeutics completes enrollment in its phase III VANQUISH-1 obesity study, surpassing targets and marking rapid progress for its VK2735 program.

image for news VKTX Completes Enrollment in First Late-Stage Study on Obesity Drug